These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24322891)

  • 1. c-FOS suppresses ovarian cancer progression by changing adhesion.
    Oliveira-Ferrer L; Rößler K; Haustein V; Schröder C; Wicklein D; Maltseva D; Khaustova N; Samatov T; Tonevitsky A; Mahner S; Jänicke F; Schumacher U; Milde-Langosch K
    Br J Cancer; 2014 Feb; 110(3):753-63. PubMed ID: 24322891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectin-independent adhesion during ovarian cancer metastasis.
    Khaustova NA; Maltseva DV; Oliveira-Ferrer L; Stürken C; Milde-Langosch K; Makarova JA; Rodin S; Schumacher U; Tonevitsky AG
    Biochimie; 2017 Nov; 142():197-206. PubMed ID: 28919578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
    Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
    BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
    Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
    Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
    Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.
    Kitami K; Yoshihara M; Koya Y; Sugiyama M; Iyoshi S; Uno K; Mogi K; Tano S; Fujimoto H; Nawa A; Kikkawa F; Kajiyama H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
    Kenny HA; Chiang CY; White EA; Schryver EM; Habis M; Romero IL; Ladanyi A; Penicka CV; George J; Matlin K; Montag A; Wroblewski K; Yamada SD; Mazar AP; Bowtell D; Lengyel E
    J Clin Invest; 2014 Oct; 124(10):4614-28. PubMed ID: 25202979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer.
    Fanelli M; Camperchioli A; Petrella L; Petrillo M; Baranello C; Baccaro P; Paolillo C; Capoluongo E; Scambia G
    Int J Biol Markers; 2018 Jan; 33(1):124-131. PubMed ID: 29218693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.
    Wang Y; Li L; Guo X; Jin X; Sun W; Zhang X; Xu RC
    Cytokine; 2012 Aug; 59(2):228-36. PubMed ID: 22595649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
    Yan Y; Jiang X; Zhao Y; Wen H; Liu G
    Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
    Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
    J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
    Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
    Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
    Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
    Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion.
    Liu S; Zhang J; Yin L; Wang X; Zheng Y; Zhang Y; Gu J; Yang L; Yang J; Zheng P; Jiang Y; Shuai L; Cai X; Wang H
    Cell Death Dis; 2020 Jun; 11(6):412. PubMed ID: 32487998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
    Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
    Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells.
    Casey RC; Oegema TR; Skubitz KM; Pambuccian SE; Grindle SM; Skubitz AP
    Clin Exp Metastasis; 2003; 20(2):143-52. PubMed ID: 12705635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.